B

Bioatla Inc
NASDAQ:BCAB

Watchlist Manager
Bioatla Inc
NASDAQ:BCAB
Watchlist
Price: 1.71 USD -14.07%
Market Cap: 82.7m USD
Have any thoughts about
Bioatla Inc?
Write Note

Bioatla Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bioatla Inc
Cash Equivalents Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
B
Bioatla Inc
NASDAQ:BCAB
Cash Equivalents
$111.5m
CAGR 3-Years
-22%
CAGR 5-Years
59%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash Equivalents
$7.3B
CAGR 3-Years
-16%
CAGR 5-Years
-7%
CAGR 10-Years
-1%
Gilead Sciences Inc
NASDAQ:GILD
Cash Equivalents
$5B
CAGR 3-Years
5%
CAGR 5-Years
-12%
CAGR 10-Years
-2%
Amgen Inc
NASDAQ:AMGN
Cash Equivalents
$9B
CAGR 3-Years
-9%
CAGR 5-Years
-5%
CAGR 10-Years
9%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash Equivalents
$6.5B
CAGR 3-Years
1%
CAGR 5-Years
14%
CAGR 10-Years
25%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash Equivalents
$2B
CAGR 3-Years
-16%
CAGR 5-Years
8%
CAGR 10-Years
12%

See Also

What is Bioatla Inc's Cash Equivalents?
Cash Equivalents
111.5m USD

Based on the financial report for Dec 31, 2023, Bioatla Inc's Cash Equivalents amounts to 111.5m USD.

What is Bioatla Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
59%

Over the last year, the Cash Equivalents growth was -48%. The average annual Cash Equivalents growth rates for Bioatla Inc have been -22% over the past three years , 59% over the past five years .

Back to Top